Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Zimmer Biomet Holdings, Inc. (ZBH) had Cost of Goods Sold of $559.30M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$2.00B
Net Income	$230.90M
Cost of Goods Sold	$559.30M
Gross Profit	$1.44B
Operating Expenses	$1.65B
Operating Income	$351.30M
Non-Operating Income/Expense	$-72.10M
Pre-Tax Income	$279.20M
Normalized Pre-Tax Income	$279.20M
Income after Taxes	$231.20M
Income from Continuous Operations	$231.20M
Consolidated Net Income/Loss	$231.20M
Normalized Income after Taxes	$231.20M
EBIT	$351.30M
EBITDA	$634.90M
Weighted-Average Shares Outstanding (Basic)	198.10M
Weighted-Average Shares Outstanding (Diluted)	198.80M
Earnings per Share (EPS) (Basic)	$1.17
Earnings per Share (EPS) (Diluted)	$1.16
Balance Sheet Financials
Current Assets	$5.83B
Property, Plant, and Equipment	$2.19B
Long-Term Assets	$17.65B
Total Assets	$23.49B
Current Liabilities	$2.40B
Long-Term Debt	$7.51B
Long-Term Liabilities	$8.32B
Total Liabilities	$10.72B
Common Equity	$12.77B
Tangible Shareholders Equity	$-1.68B
Shareholders Equity	$12.77B
Common Shares Outstanding	198.20M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.18B
Cash Flow from Investing Activities	$-1.65B
Cash Flow from Financial Activities	$1.22B
Beginning Cash	$525.50M
End Cash	$1.29B
Increase/Decrease in Cash	$767.20M
Stock-Based Compensation	$66.10M
Common Stock Dividends Paid	$-142.80M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.43
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.37
Debt to Equity Ratio	0.64
Gross Margin	72.05%
Operating Margin	17.55%
EBIT Margin	17.55%
EBITDA Margin	--
Pre-Tax Profit Margin	13.95%
Profit Margin	11.54%
Free Cash Flow	$803.80M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.23
Receiveable Turnover	1.25
Days Sales in Receivables	71.87
Return on Equity	1.81%
Return on Tangible Equity	-13.80%
Return on Assets	0.98%
Return on Investments	1.14%
Book Value Per Share	$64.41
Free Cash Flow per Share	$4.04
Operating Cash Flow per Share	$5.93

Data from Zacks Investment Research, Inc.